fig3
![Safety and efficacy of DEM-TACE performed with drug-eluting microspheres smaller than 300 μm in patients with HCC and TIPS](https://image.oaes.cc/ad1c17e8-4f5a-4f4e-85b7-ef1f96302a7a/4687.fig.3.png)
Figure 3. A: 58-year-old man with hepatitis C virus-related cirrhosis (Barcelona Clinic Liver Cancer Stage A; Child- Pugh Score B7) with a 4334 mm VII segment subcapsular HCC nodule. A: Multiphasic CT demonstrates typical wash-in (arrows) in the arterial phase and late wash-out at the delayed phase. B:Superselective catheterization was achieved (score 1) and 100% of 100 μm microspheres were administered. C: Follow-up CT at 12 months after the procedure demonstrates no residual vital tissue (arrows) categorizing the patient as having CR.